Martin Kristian Raida

Martin Kristian Raida holds a MSc and a Ph.D. degree in Immunology & Microbiology. He has worked with vaccine development for more than 9 years, the last 5 of them as associate professor leading a high performing multinational research group within bacteriology, immunology, and vaccine development. He has solid management experience within industrial manufacturing of pharmaceutical products. Martin joined Bavarian Nordic in 2014 as Manager of quality control (QC) and participated in the fast track validation of the Filo-vaccine used during the Ebola outbreak in West Africa. Later, he joined Novo Nordisk BioPharm where he headed a team of academics responsible for QC microbiology analysis supporting several production sites.
Position COO since 2019
Year of Birth 1977
Holding of shares in Cytovac AB
(as of Dec 31, 2018)
Other ongoing assignments Martin Kristian Raida does not have other ongoing assignments.
Previous Assignments (within the last 5 years) Associate professor at University of Copenhagen, QC manager at Bavarian Nordic, Team leader at Novo Nordisk BioPharm.
Independent in relation to the company and its management Yes
Independent in relation to larger shareholders Yes

Error, cant find that post.